ABIO - Arca Biopharma, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - In Vitro & In Vivo Diagnostic Substances - ABIO (907654)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
20 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2022-05-23
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.32+85,2622,580,452+3%+$197,404
DM
2022-05-18
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.30+13,0732,495,190+1%+$30,128
DM
2022-05-12
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.29+84,8362,482,117+4%+$194,143
DM
2022-05-10
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.28+45,5752,397,281+2%+$104,128
DM
2022-05-05
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.28+124,1222,351,706+6%+$282,563
DM
2022-04-28
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.31+33,6142,227,584+2%+$77,730
D
2022-04-25
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.29+13,7512,193,970+1%+$31,508
D
2022-04-18
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.31+9,1192,180,2190%+$21,080
2022-04-14
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.33+17,4102,171,100+1%+$40,546
M
2022-04-08
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.32+104,7132,153,690+5%+$242,729
M
2022-04-05
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.31+103,9842,048,977+5%+$239,778
A
2022-04-04
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.26+122,3421,944,993+7%+$276,309
2022-04-04
ABIOFunicular Fund, LPSee Footnote 1P - Purchase$2.26+122,3421,944,993+7%+$276,309
2021-11-22
ABIOOzeroff Christopher DavidS.VP, GCP - Purchase$2.26+50,00050,970>999%+$113,210
2021-05-12
ABIOConway Robert EChairman of the BoardP - Purchase$3.19+10,00050,000+25%+$31,947
2021-05-05
ABIOConway Robert EChairman of the BoardP - Purchase$3.23+10,00040,000+33%+$32,345
2020-12-18
ABIOConway Robert EChairman of the BoardP - Purchase$4.16+10,00030,000+50%+$41,630
2020-09-25
ABIOConway Robert EChairman of the BoardP - Purchase$4.28+5,00020,000+33%+$21,400
2020-09-22
ABIOConway Robert EChairman of the BoardP - Purchase$4.66+3,05615,000+26%+$14,241
2020-09-21
ABIOConway Robert EChairman of the BoardP - Purchase$4.77+10,00011,944+514%+$47,660

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top